CIA
AZN icon

CCM Investment Advisers’s AstraZeneca AZN Stock Holding History

CCM Investment Advisers’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$275K Sell
1,450
-43
-3% -$8.09K 0.02% 80
2026
Q1 		$294K Sell
1,493
-1
-0.1% -$193 0.03% 78
2025
Q4 		$275K Sell
1,494
-27
-2% -$4.74K 0.03% 74
2025
Q3 		$233K Buy
+1,521
New +$230K 0.02% 80

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

CCM Investment Advisers's AZN Position: Q2 2026 in Review

CCM Investment Advisers reduced its AstraZeneca (AZN) stake by 2.9% in Q2 2026, selling an estimated $8.09K and leaving 1,450 shares worth $275K. The position accounts for 0.02% of the portfolio, ranked #80.

CCM Investment Advisers first reported a position in AZN in Q3 2025 and has held it in 4 quarters since. The position peaked at $294K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • CCM Investment Advisers held 1,450 shares of AstraZeneca worth $275K as of Q2 2026.
  • CCM Investment Advisers sold 43 AstraZeneca shares in Q2 2026, an estimated $8.09K.
  • AstraZeneca made up 0.02% of CCM Investment Advisers's portfolio in Q2 2026, its #80 holding.
  • CCM Investment Advisers first reported a position in AstraZeneca in Q3 2025 and has held it in 4 quarters since.
  • CCM Investment Advisers's AstraZeneca position peaked at $294K in Q1 2026.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on CCM Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.